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1 Executive Summary
The first six hours following orthopedic implantation is a decisive period for preventing bac-
terial adhesion to ensure an implant’s long-term success. If bacterial adhesion is not adequately
impeded, a biofilm will form, acting as a diffusion barrier to slow down the implant integration
process. Current therapies to treat osteomyelitis and other forms of implant-related infections in-
clude physical removal of the infected device, revision surgery, and prolonged antibiotic therapy.
However, osteomyelitis still occurs at significant rates, and affected patients often require surgical
adjustment or systemic antibiotic dosages.
This project considers a cylindrical drug-eluting pin, comprised of a reservoir of packed meso-
porous silica MCM-48 microparticles, where the antibiotic (linezolid) is adsorbed. As simulated
body fluid flows into the pin, the drug is desorbed from the microparticles and diffuses down its
concentration gradient to be released in a sustained manner. A one dimensional diffusive mass
transport simulation in COMSOL 5.3 Multiphysics was used to quantitatively simulate this process
with the objective of optimizing design options such as porosity and pin geometry with respect to
drug delivery, specifically the concentration of the drug on the surface of the pin where bacterial ad-
hesion occurs. We modeled a pin with 17% wall porosity packed with 440 nm silica beads. These
dimensions can be altered to improve current fixation pin designs which can facilitate treatment
procedures.
Our model exhibited higher rates of release when compared to the experimental data, with
50% of total drug release achieved at approximately 8.5 and 40 hours respectively. This can be
explained by the limited volume of SBF used in the experiment in contrast to the “infinite” amount
of SBF that was assumed in our model, leading to higher rates of diffusion and release in our
computational model. Optimization of porosity revealed that 20% porosity leads to a drug release
profile that maximizes the amount of time above the minimal bactericidal concentration (MBC) and
minimal inhibitory concentration (MIC). In the design of future pins, since increases in porosity are
associated with decreases in mechanical strength and increases in manufacturing costs, the resulting
changes in the mechanical properties and manufacturing process are significant factors that must
be taken into account when improving the existing design of orthopedic devices.
Keywords: porous stainless steel, mesoporous silica beads, linezolid, orthopedic fixation pin,
1D diffusion.
2 of 27
2 Introduction
Orthopedic devices designed to treat open fractures exhibit comparatively higher rates of in-
fection than other types of orthopedic devices, due in part to the closer proximity of fractures to
the skin surface [1]. Many current open fracture devices use fixation devices (e.g., pins, nails, and
plates) directly connected to the bone for stabilization during the healing process. However, this
connection between skin and tissue presents a critical entry point for bacteria and other infectious
organisms. Implant-related infections account for 15% of all hospital-origin infections and are the
most common types of infections among surgical patients [2]. While frequent cleansing of de-
vice pins can help attenuate bacterial infection, osteomyelitis (an infection of the bone) still occurs
in open fractures at a rate that is significantly higher than in other types of orthopedic injury [3].
The first six hours following orthopedic implantation has been identified as the decisive period for
preventing bacterial adhesion and is critical for an implant’s long-term success [4]. If bacterial
adhesion is not adequately impeded, a biofilm will form, acting as a diffusion barrier to slow down
the penetration of nutrients and antimicrobial agents. As a result, treatment becomes much more
difficult, with affected patients often requiring additional treatments including systemic antibiotic
treatment or surgical adjustment [5].
Current research on medical therapies to treat bacterial adhesion and subsequent biofilm growth
on medical implants have an overall success rate of 57% to 88% [6], and incur significant economic
expenditures. Some of these therapies include the physical removal of the infected medical device,
radical debridement or physical removal of the infected tissue, revision surgery, prolonged antibiotic
therapy, and the use of anti-adhesive medical devices [6]. The invasive nature of debridement and
revision surgery has driven the discovery of less detrimental techniques. Standard medical protocols
to treat osteomyelitis, such as systemic delivery of antibiotics, suffer from drawbacks of systemic
toxicity and poor penetration into target tissue. The prevention of orthopedic device-related infec-
tions (ODRI) through the development of anti-adhesive medical surfaces involves the coating of
these device surfaces with compounds and antibiotics [7]. One strategy that uses a specific type of
coating to prevent ODRI is the use of an ionic silver coating on the device surface. It is effective
due to silver’s broad spectrum of antibacterial activity in reducing infection rates. Another method
is local antibiotic release from polymethyl methacrylate (PMMA)-based bone cements. However,
a second surgery is required in this process to remove the PMMA beads, making this method non-
ideal for the prevention of osteomyelitis [8]. In addition, prolonged antibiotic therapy can build up
a patient’s antibiotic resistance, leading to possible lifetime impairment. All of these factors make
up the demand for advancement in ODRI research.
Since recognizing the need for local delivery of antibiotics immediately following implanta-
tion, more research has been conducted in identifying problems with the current systemic approach.
Some issues with current prevention techniques include the poor penetration of antibiotics into is-
chemic and necrotic tissue [9]. This can be corrected by maintaining a high local drug concentration
for a short period of time so as to prevent buildup of a toxic concentration in the overall system. The
effectiveness of a system designed to prevent ODRI strongly depends on two factors. The first is
the rate of release of the drug [9]. The rate of release can affect a variety of factors, including ease
of management of the drug, development of antibiotic resistance, the probability of eradicating the
infection, etc. The other major factor affecting the efficacy of the system is the sustained release of
the drug [10]. The sustained release of the drug at an effective level is necessary to prevent infection
by latent bacteria. Current prevention and treatment practices are not optimized for either factor,
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creating the need for a new system to be implemented.
The modelling and analysis of the drug-eluting pin aims to maximize the efficiency of antibiotic
release and decrease the risk of infection after surgical treatment of bones. As more drug-eluting
orthopedic implants have been developed, a new subcategory emerged: drug-filled orthopedic im-
plants. These implants utilize the hollow space inside the implant as reservoirs for drug delivery
without compromising the structural integrity of the implant. They aim to eliminate local infections
by initiating the controlled drug release promptly after surgery. So far, three different designs of
drug-filled orthopedic fixation pins have been studied in in vitro and in vivo studies.
The first design is a stainless steel hollow tubular fixation pin with antibiotic powder packed in
the interior space of the pin and several orifices drilled in the reservoir wall to allow drug release
[11]. The second design alters the structure of the wall of the fixation pin to be porous, while the
hollow space inside the pin is still packed with antibiotic powder [11]. The third design has the same
porous wall design, but uses a bed of mesoporous silica particles with the antibiotic adsorbed onto
them, replacing the antibiotic powder [8]. This particular pin design includes two sets of variables
that can be controlled independently–the properties of the porous wall and the properties of the
mesoporous silica particles [8]. The antibiotic is first released from the mesoporous silica particles
when the tissue fluid enters the silica bead matrix. It then diffuses through the porous wall of the
fixation pin into the surrounding liquid environment. This two-stage release offers greater flexibility
for tailoring the drug release profile [12]. Bactericidal and mechanical studies were performed on
the prototypes for this fixation pin design, and the drug release over time was recorded. This design
is shown to provide a significant reduction of bacterial growth. However, in this study, Perez et
al. [8] did not model the physics of the tissue fluid and drug diffusion into and out of the pin.
In addition, the group was unable to successfully reproduce the constant fluid flow outside of the
implant as in a real-life setting, instead using an in vitro setup with 100 mL of simulated body fluid
(SBF) with stirring [12].
Figure 1: X-ray images showing fractures in the fibula and tibia shafts treated with plates and metal
pins inserted into the plate frame to stabilize and realign the bone.
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3 Problem Statement
Our project builds on the orthopedic fixation pin design proposed by Perez et al. [8]. The pro-
cess being modeled is the diffusion of antibiotic particles that have been adsorbed onto mesoporous
silica beads, packed in a hollow stainless steel orthopedic fixation pin. The drug is desorbed from
the beads as the SBF diffuses into the silica bead matrix, and diffuses out through the porous steel
wall into the simulated body fluid (SBF) outside the pin. This project will provide physical mod-
eling to test the Perez et al.[8] implant design. It may also provide a basis for future directions to
optimize the drug release profile by varying parameters such as the diameter and quantity of the
silica beads, or the porosity of the beads or the pin wall without compromising the mechanical
capabilities of the pin.
Given the complex nature of the problem, it is difficult to characterize the effects of varying
fixation pin design parameters such as the porosity and thickness of the titanium wall and initial
concentration of drug loaded onto the silica matrix on the release kinetics of the antibiotic, Line-
zolid. Prior in vitro and in vivo experiments do not provide information on the effects of these
parameters on drug release. Without detailed characterization of the device, further design opti-
mization is difficult. In vivo experiments are costly and time consuming, requiring numerous trials,
and thus are not generally feasible for design studies. Computational modeling, on the other hand,
is far less resource demanding, and allows users to easily tweak and alter parameters in order to
quantify the effects on the system of interest.
3.1 Design Objectives
The primary objective of modeling this system in COMSOL was to optimize the time taken
to release all of the drug adsorbed on the mesoporous silica bead matrix by varying parameters
throughout the drug release process without compromising the mechanical properties of the fixation
pin. Our initial computation measures the change in concentration of SBF as it diffuses through
the porous stainless steel pin wall and through the mesoporous silica bead matrix at the center of
the pin. The change in concentration of the drug as it diffuses out of the silica matrix and out
of the porous pin wall is also measured simultaneously. By varying combinations of both SBF
diffusivity values and drug diffusivity values in the wall and the matrix, we can compare the results
over a period of time. A minimum concentration of the drug must be released within the first six
hours to inhibit the formation of a biofilm, and the drug should have a sustained release period
following the initial release phase. Therefore, to optimize the given system, the effects of design
parameters such as porosity, wall thickness, and initial drug concentration are compared with the
objective of minimizing the time taken to reach the critical bactericidal drug concentration required.
In modeling this process, we hope to:
1. Compute sensitivity of release kinetics to fixation pin design parameters (e.g. porosity, wall
thickness, initial drug concentration).
2. Determine in isolation the sensitivity of release kinetics to changes in material properties,
such as diffusivity.
3. Compare the relative sensitivities to fixation pin design parameters and changes in material
properties to make a concrete claim regarding which combination of parameters is the most
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important in achieving a drug release profile capable of inhibiting formation of a biofilm.
3.2 Schematic
This cylindrical drug-eluting pin is comprised of a reservoir of packed mesoporous silica MCM-
48 microparticles contained within the porous 316L stainless steel wall, as shown in Figure 2.
Linezolid, a synthetic antibiotic, has been adsorbed onto the silica beads prior to the assembly of
the pin. One end of the pin is sealed with a blind end cap, while the other end is capped with a
polytetrafluoroethylene (PTFE) conical plug after the drug-loaded silica beads have been loaded [8].
The initial conditions and boundary conditions for our system are noted in section 5.0 on a figure
of the schematic (Figure 3) and the exact equations are noted in Appendix A2. The governing
equations are discussed in section 4.0.
Figure 2: (A) Size comparison between the drug-eluting pin next to a 1 coin. [8] (B Simplified
schematic of the two-domain system of one drug-eluting pin that was modeled in COMSOL. (C)
The physics of the SBF and linezolid diffusions through the porous wall and silica beads. (D)
Arrangement of mesoporous silica beads inside the cylinder [13].
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The dimensions and designed material properties of the pin, porous stainless steel wall, and
mesoporous silica MCM-48 microparticles are recorded in Table 1.
Table 1: Dimensions and Properties of the Hollow-Porous Pin
Dimension Value
Pin
Outer diameter 6.25 mm
Outer radius 3.125 mm
Length 25.4 mm
Inner radius 1.525 mm
Porous wall
Porosity of wall 17%
Thickness of wall 1.6 mm
Nominal pore size 200 nm
Silica beads Bead diameter 440 nmAverage pore diameter 3.49 nm
3.3 Qualitative Description of the Process
The cylindrical drug-eluting pin is modeled as a 1D diffusion problem implemented as 2D ax-
isymmetric along the entire length of the pin due to axial symmetry along the z-axis. The antibiotic
Linezolid is adsorbed onto spherical mesoporous silica particles, which are packed into a hollow
pin with a porous stainless steel wall. The packed pins are then immersed into simulated body fluid
(SBF) which diffuses into the pin through the porous wall. The drug is eluted from the silica beads.
The drug migrates through the silica particles, then exits the pin through the porous wall by simple
capillary diffusion, where it is ultimately released into the surrounding body fluid.
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4 Governing Equations and Boundary Conditions
4.1 Governing Equations
The mass transfer physics are used to model two species – linezolid and SBF. As shown in
Figure 2, the modeling system contains two domains –the inner matrix made of drug-containing
silica particles and the porous stainless steel wall. The drug and SBF concentrations at the interface
between the two domains are continuous, so no boundary condition was required. The process is
modeled for in vitro testing of the drug-eluting pin [8].
Both mass transfer processes are modeled as one dimensional transient diffusion in the radial
direction. The axisymmetry of the pin simplifies the model to a two dimensional geometry. The
consistent drug concentration throughout the matrix of the pin reduces any significant differences
in the axial direction, thus making this a one dimensional problem. The SBF diffuses through the
porous wall and the inner matrix made of silica beads. The drug, linezolid, diffuses out of the inner
matrix and the porous wall as SBF enters. The governing equations used for SBF and drug diffu-
sions are listed below.
SBF diffusion:
[0 <r <R]
δCSBF
δ t
= DSBF,matrix(
1
r
δ
δ r
(r
δCSBF
δ r
)) (1)
[R <r <(R+T)]
δCSBF
δ t
= DSBF,wall(
1
r
δ
δ r
(r
δCSBF
δ r
)) (2)
Drug diffusion:
[0 <r <R]
δCD
δ t
= DD,matrix(
1
r
δ
δ r
(r
δCD
δ r
)) (3)
[R <r <(R+T)]
δCD
δ t
= DD,wall(
1
r
δ
δ r
(r
δCD
δ r
)) (4)
Meanwhile, the drug diffusivity and SBF diffusivity values in the matrix depend on changes in
SBF concentration in the matrix. They are calculated based on the following equations found in
[14].
SBF diffusivity through silica beads (matrix):
DSBF,matrix = DSBF,eqe
−β1(1− CSBFCSBF,eq ) (5)
Drug diffusivity through silica beads (matrix):
DD,matrix = DD,eqe
−β2(1− CSBFCSBF,eq ) (6)
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Table 2: Symbols used in the governing equations.
Variables and Solvers
SBF Concentration CSBF
Drug Concentration CD
Radial distance from the central axis of the cylindrical pin r
Time starting with SBF entering the porous steel wall t
Diffusivity of drug through the silica beads in the inner cylinder DD,matrix
Diffusivity of SBF through the silica beads in the inner cylinder DSBF,matrix
4.2 Boundary and Initial Conditions
The geometry is simplified as a 2D axisymmetric model about the central axis of the drug-
eluting pin. For the top surface sealed by the PTFE cap and the bottom sealed surface of the pin,
the diffusive flux equals zero. Because the external SBF solution is being stirred, the boundary
condition of drug diffusion is the outward flux due to the convective SBF flow along the right outer
wall surface in Figure 3 below.
The initial conditions for the model designate an initial drug concentration within the silica bead
matrix on the left, while there is no initial concentration of either drug or SBF throughout the rest of
the model. The exact equations used for the initial and boundary conditions are noted in Appendix
A2.
Figure 3: Simplified schematic and boundary conditions for the model are shown.
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5 Results
Obtaining a drug concentration above the MIC and MBC values ensures that the concentration
of antibiotic released is able to effectively prevent the growth of bacteria. To evaluate the calculated
solution in COMSOL, the following graph was created to show the drug concentration release
over a time period of 160 hours. The MIC and MBC values are indicated with the red and green
horizontal lines. The drug concentration exceeds the minimum concentration needed to treat the
bacteria within the first 5-160 hours of release.
Figure 4: Drug concentration at the wall of the pin over time with MIC (0.00593 mol/m3) and
MBC (0.04743 mol/m3) values shown
In Figure 4, the drug concentration over time at the wall of the pin initially increased as the drug
releases from the inner silica bead matrix. After about 20 hours, the drug concentration at the wall
experienced a first order decrease. During the initial few hours, the drug concentration at the wall
rapidly surpassed the MIC of 0.00593 mol/m3, and the MBC of 0.04743 mol/m3. This desired high
antibiotic concentration remained until about the 100th hour for MBC and about the 160th hour for
MIC. In addition to monitoring the amount of drug concentration that effectively prevents bacterial
growth, we ensured that the total amount of linezolid contained inside the pin does not approach
the toxic level for this drug within the body even if all of the drug were released at once [8].
This modeling result is consistent with the sustained release indicated by the Perez et al. [8]
study. We can visualize the drug concentration profiles from the central axis of the fixation pin to the
wall at different times of the drug release process (Figure 5). Initially, all of the drug concentration
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was contained in the silica matrix while the porous stainless steel wall had no drug. As time went
on, the inside drug concentration decreased as the drug diffused out through the SBF in the matrix
and the porous wall, and was carried away by the convective flow outside of the pin.
Figure 5: (A) Drug concentration plotted over distance from the central axis of the pin to the wall,
at different times. (B) Zoomed in section showing the decrease in drug concentration profile over
time close to the outside of the porous steel wall.
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6 Discussion
6.1 Validation
Comparing the results of our simulated drug release to the results from literature Perez et al. [8],
the linezolid release profile over time appears similar. Figure 6 below shows that the drug release
from the experimental data is slower compared to the values we computed. This can be accounted
for by the limited volume of SBF used in the in vitro experiment in contrast to the “infinite” amount
of SBF that we have assumed in our model. The experiment uses 100 mL of SBF which will slowly
become saturated with the drug, resulting in a slower release rate. In our model the SBF outside the
pin is stirred and constantly renovated, preventing the accumulation of linezolid in the fluid around
the pin. Our model is more similar to the in vivo set up for the pin where the tissue fluid would be
constantly circulated, maintaining a steep gradient for the drug release from the pin.
Figure 6: Linezolid released as a percentage of linezolid initially loaded into the pin for the com-
puted data using our model and the experimental data from Perez et al. [8].
The objective of this device is to prevent bacteria film formation during the critical period (first
six hours after implantation), and to continue to inhibit and control bacterial growth 48 hours after
implantation [8]. Thus, the drug concentration in the wall should be above the minimum bac-
tericidal concentration (MBC) for at least the critical period, and above the minimum inhibitory
concentration (MIC) for the growth of bacteria up to a minimum of 48 hours after implantation.
For the bacterium Staphylococcus aureus, the MBC and MIC are 0.04743 mol/m3 and 0.00593
mol/m3 respectively. Our model is consistent with these values based on the data obtained to gen-
erate Figure 4 which shows the concentration of the drug at cut point 2, very close to the exterior
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of the pin.
6.2 Sensitivity Analysis
Sensitivity analyses were performed by observing how the results of the model change due to
uncertainty in input parameters (e.g.,DD,SBF ,DSBF,wall ,DD,wall , etc.). To accomplish this, literature
values of parameters of interest were varied by 10% and the percent changes in final concentration
of the model results were observed. Specifically, the changes in concentration at the surface of the
pin, six hours after the pin has been implanted, were observed. The first six hours are critical in
the prevention of bacterial film formation, which is the root of orthopedic post-op infections. The
concentration of the drug at the interface between the outer wall of the steel pin and the surrounding
SBF determines if the drug will kill, inhibit the growth of, or allow propagation of the bacteria. For
an initial examination of the model’s sensitivity to variations in various diffusivities, we varied
DD,eq, DSBF,eq, DSBF,wall , DD,wall , and hout (see Table 3 in Appendix A.3 for definitions) by 10% at
the surface of the pin at t = 6 h.
Figure 7: Sensitivity analysis of 10% change in drug and SBF equilibrium concentrations at the
porous wall.
The largest change in solution result occurred due to changes in DSBF,wall and DD,wall . A The
largest change in drug concentration occurred due to changes in DSBF,wall and DD,wall . A decrease
and an increase of 10% of DSBF,wall led to a 19.15% decrease and a 20.96% increase respectively.
Similarly, a decrease and an increase of 10% of DSBF,wall led to a 23.09% decrease and a 28.06%
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increase respectively. Of the parameters examined above, our model exhibits the greatest sensitivity
to changes in DSBF,wall and DD,wall .
6.3 Optimization
The drug concentration on the outside surface of the pin is the most important variable to prevent
bacterial infection. For the purposes of explaining our optimization process, this concentration shall
be referred to asCdrug. There are two time points that are essential for this process to be at maximum
efficiency: the time point at which Cdrug exceeds the minimum bactericidal concentration (MBC),
referred to as t1; and the time point at whichCdrug falls below the minimum inhibitory concentration
(MIC), referred to as t2. The ideal system would minimize t1, thereby allowing the bacteria very
little time to form a film on the pin’s surface, while maximizing t2, inhibiting bacterial growth for
long periods of time after implantation. Finally, t1 needs to be positioned within the first six hours
after implantation, since that is the period in which the pin is most vulnerable to bacterial adhesion
and film formation, which can later lead to infection [4]. The material property we chose to vary
to achieve these changes in t1 and t2 was porosity. We quantified this ideal behavior using three
functions:
F1(t) = t1 for c >MBC; 0 for c <MBC (7)
F2 (t = 6hrs) = 1 for c >MBC; 0 for c <MBC (8)
F3(t) = t2 for c >MIC; 0 for c <MIC (9)
Here, F1 can be used to minimize t1, F2 ensures that t1 occurs within the first six hours, and F3
can be used to maximize t2. The three functions were combined to form an objective function that
could be maximized to find an optimal porosity for the porous steel wall of the pin, shown below:
J = F2 (F1 + 10*F3) (10)
Here, F3 is given a weight of 10 to ensure that the value of J is not determined by the absolute
difference between t1 and t2, but rather by the individual values of the two times. We chose to weight
F3 more heavily because maximizing t2 would be more effective in preventing bacterial propagation,
rather than minimizing t1; Cdrug continues to decimate the bacteria while it stays above the MBC,
which it does for the majority of the experiment, as can be seen from Figure 4. The variation of the
objective function with respect to porosity is shown in Figure 8.
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Figure 8: The objective function is maximized at 20% porosity of the stainless steel wall.
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7 Conclusions and Recommendations
According to the sensitivity analyses conducted on the solution results, we decided to focus
specifically on the sensitivity of our model to variations in DSBF,wall and DD,wall . The preliminary
calculations of these values are shown in Appendix C, using the equation for the diffusion of a
solute in a saturated porous system presented in [15]. Through this relationship, we observed that
the diffusivity values could be altered most effectively by varying the porosity values within our
model.
By implementing an objective function that determines the optimal porosity for the porous steel
wall of the pin, we were able to address our final design objective of determining an optimal com-
bination of parameters for a drug release profile that best inhibits biofilm formation.
The results of the maximized objective function indicate that the optimal design occurs at 20%
porosity, yielding a drug release profile with the greatest range of time above the MBC and MIC
values. The initial concentration of drug release rises to about 22 times the MBC value as seen
in Figure 4, indicating that the Linzeolid concentration far exceeds the required bactericidal con-
centration value within the first 24 hours. To further improve this system, we decided to focus on
maximizing the amount of time that the drug continues to remain above the MIC value over a long
period of time, as shown in the objective function. By optimizing the amount of time during which
the drug successfully inhibits bacterial propagation while maintaining a sufficiently high initial drug
release profile within the first six critical hours, we are able to apply this optimal porosity value of
20% to the design parameters for the porous pin wall.
7.1 Design Constraints and Considerations
Use of these hollow porous stainless steel pins for orthopedic applications means they must
be able to withstand the significant mechanical stresses associated with both normal and active
movement. The porous steel pin used in this experiment could withstand compressive stresses of
up to 300 MPa without plastic deformation [8]. For reference, the ultimate compressive stress
supported by human bones has been estimated to be 196 MPa [16]. Thus, any alterations in the
design of the pin must be made with the pin’s mechanical properties in mind. Since increases in
porosity decreases the strength of the pin and leads to lower values for the ultimate compressive
strength, attention must be paid to ensure that newly manufactured pins with altered porosity still
possess the mechanical properties necessary to withstand physiological stresses.
In addition, increases in porosity means the stainless steel wall material is thinner. This leads
to increased difficulty in manufacturing, as more care is required to ensure continuity and precision
over all parameters [17]. The additional precision required in these cases leads to increases in
cost associated with higher porosity pins. However, it is important to note that high porosity pins
were found to improve osseointegration, as the surface area available for bone growth is increased.
In summary, when adjusting porosity and pin geometry, the resulting changes in the mechanical
properties and the manufacturing process are significant factors that must be taken into account.
Since increases in porosity are associated with both higher cost and increased osseointegration
potential, these two effects should be weighed accordingly to reach a final design decision.
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7.2 Future Recommendations and Improvements
Our model of the linezolid release over the first 160 hours after implantation provides valuable
insights to the drug eluting physics of the Perez et al. [8] fixation pin design. The drug release
kinetics of the current design is highly sensitive to changes in the diffusivities of SBF and linezolid
in the porous stainless steel. In comparison, the diffusivities of SBF and linezolid in the silica matrix
have limited effects to the drug release kinetics. This modeling result suggests that the design of
the pin wall is critical for achieving rapid release in the first six hours and maintaining sustained
long-lasting release. Taking into account these optimization criteria, our objective function gives
an optimal porosity of 20% for the pin wall for the current design.
Theoretically, a well-defined and well-controlled design for the drug-eluting fixation pin should
follow a two-phase zeroth order release profile. In the first phase, a high constant release rate
enables the drug concentration at the outer surface of the pin wall to quickly raise above MBC.
In the second phase, a constant release rate of nearly zero should be maintained for an extended
period of time to stabilize the drug concentration above MIC and within the therapeutic window
for linezolid function.
In order to effectively characterize and improve upon the current design of the fixation pin,
additional experiments are required. Our model has indicated that the current in vitro set up of the
Perez et al. [8] drug release experiment requires improvements in order to more accurately represent
the fluid flow conditions in vivo near the human bone. Instead of renovating SBF after 160 hours,
the outside SBF should be flowing over the surface of the pin, generating convective flux on the
surface of the pin wall. After improving experimental set up, a series of additional mass transfer
tests should be performed to obtain the effective diffusivities of the SBF and linezolid in the silica
matrix and in the porous wall. Additional material properties of the silica matrix and the pin wall
should also be measured experimentally, to enable to more accurately mathematical modeling and
more effective design modification.
For future modeling of the drug release process, an alternative computational model can be
constructed and tested against ours for validity. In this model, SBF enters into the porous wall
by capillary flow instead of simple diffusion. A small scale model is implemented to estimate the
effective diffusivity of SBF as it flows through the interstitial spaces in between the silica beads, in
addition to the changing effective diffusivity of linezolid with changing SBF concentration. This
alternative model uses more accurate physics than the single diffusive mass transfer used in our
current computational model; it takes into account the tortuosity of the fluid as it travels between
the silica beads, as well as the fluid flow that can occur in the pores of the stainless steel wall. We
were not able to implement this model because of a lack of data available for all the parameters
required. Due to the sensitivity of the values with respect to the dimensions, the drug used, and
the composition of the fluid (SBF), it is difficult to find accurate values for the exact specifications
for our model. Thus, some experimental data would need to be obtained in the future before this
alternative model can be implemented.
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Figure 9: Potential geometry of the small-scale model. Mesoporous silica beads are tightly packed
into an array.
This model can be used to test for the suitability of other materials to make the pin while the pa-
rameter values for properties associated with it can be obtained. One alternative could be titanium.
Titanium has many biomedical applications, including orthopedic implants. Titanium orthopedic
devices tend to be more costly compared to their stainless steel counterparts [18]. However, tita-
nium has been found to cause less pain than stainless steel implants, and has a lower chance of
loosening from the original location of implantation, a problem that leads to the premature removal
of many orthopedic fixation pins [19]. Titanium has not been found to be more susceptible to bac-
terial infections compared to stainless steel [20]. The mechanical properties of the pin must also be
taken into account. The diffusivity of linezolid and SBF would be different in the titanium pin, and
may require a different porosity, which would affect the mechanical properties of the pin. Thus,
without determining the pore sizes and porosity required for the pin, it is not possible to have an
accurate comparison of the mechanical properties between the titanium pin and the stainless steel
pin. Using this simulation or an improved version of it to test for the viability of a titanium implant
of the same design would be one way to use this model to further improve treatment procedures.
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Appendices
Appendix A: Mathematical statement of the problem
A1. Exact form of governing equation
As described and discussed in the Section 3.0, the exact form of governing equations used for
SBF and drug diffusions in the silica matrix and in the porous stainless steel wall are listed below.
Since these equations have been used earlier in the report, they retain their original numbers.
SBF diffusion:
[0 <r <R]
δCSBF
δ t
= DSBF,matrix(
1
r
δ
δ r
(r
δCSBF
δ r
))
(1)
[R <r <(R+T)]
δCSBF
δ t
= DSBF,wall(
1
r
δ
δ r
(r
δCSBF
δ r
))
(2)
Drug diffusion:
[0 <r <R]
δCD
δ t
= DD,matrix(
1
r
δ
δ r
(r
δCD
δ r
))
(3)
[R <r <(R+T)]
δCD
δ t
= DD,wall(
1
r
δ
δ r
(r
δCD
δ r
))
(4)
Meanwhile, the drug diffusivity and SBF diffusivity values in the matrix depend on changes in
SBF concentration in the matrix. They are calculated based on the following equations found in
[14].
SBF diffusivity through silica beads (matrix):
DSBF,matrix = DSBF,eqe
−β1(1− CSBFCSBF,eq )
(5)
Drug diffusivity through silica beads (matrix):
DD,matrix = DD,eqe
−β2(1− CSBFCSBF,eq )
(6)
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A.2 Exact form of the initial and boundary conditions
As described in Section 4.0, the geometry is simplified as a 2D axisymmetric model with zero
flux at the sealed PTFE cap of the pin, and the sealed bottom of the pin, and a convective convective
flux boundary condition along the right outer wall surface.
For the porous wall,
SBF concentration outside the pin: CSBF= 1025 kg/m3 = 56869 mol/m3
(11)
Diffusion flux of drug:
−DδCD
δ t
= h(CD,r+T −CD∞)
(12)
The initial values are generated based on the loading situation of the drug and SBF inside the
pin at time zero [t = 0].
[0 <r <R]:
CD =CDi
(13)
CSBF = 0
(14)
[R <r <(R+T)]:
CD = 0
(15)
CSBF = 0
(16)
20 of 27
A.3 Drug and SBF Parameters and Constants
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Appendix B: Solution Strategy
B1. Computational Methods
This COMSOL model used time-dependent solver, PARDISO, to solve the algebraic equation.
Since drug release is a transient process, the Backward Differentiation Formula (BDF) was used
for time stepping, with a minimum order of 1 and a maximum order of 2. This model allows for
an absolute tolerance of 0.1, and a relative tolerance of 0.01. For example, at time point six hours
following implantation, the maximum error allowed in the drug concentration at the surface of the
pin is (0.1 + 0.001*CD) mol/m3, whereCD is the concentration of the drug at that time.
B2. Mesh
Our mesh was built using the mapped mesh function with two distributions. Since the geometry
of our model was fairly simple, we did not have to develop a complicated mesh for our calculations.
Our mesh is shown in the figure below:
Figure 10: Mapped mesh with the silica matrix domain on the left connected with the porous wall
domain on the right.
A mesh convergence was performed to assure that the results obtained by the simulation were in-
dependent of mesh. To accomplish this, the number of elements were increased until the computed
concentration of drug in cut point 2 on the outside of the porous steel wall at five hours was fairly
constant. We chose to carry out the mesh convergence at this point because the drug concentration
at this point is what controls the bacterial growth. We chose the time point five hours because the
first six hours are critical to control bacterial growth and the concentration at this time point should
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not be dependent on the number of mesh elements. The solution converged at approximately 40,000
mesh elements per domain, as can be seen in the figure below:
Figure 11: Mesh convergence graph showing drug concentration variation based on number of
mesh elements per domain.
The resulting mesh at the point of convergence had a total of 80,000 elements, 80,661 mesh
vertices, 1820 edge elements, 6 vertex elements, with a minimum and average element quality of
1.0, and 161322 degrees of freedom (DOF), with 4656 internal DOFs.
B3. CPU time taken and memory used by a typical run
For our mesh with 80,000 elements, the total time taken to compute the solution was 8 minutes
and 36 seconds. 1.68 GB of physical memory was used and 1.9 GB of virtual memory was used
during this calculation. This is summarized in the screenshot taken from COMSOL below:
Figure 12: Time taken and memory used for a typical run to obtain the solution.
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Appendix C: Parameter Calculations
1. Diffusivity of SBF through the porous steel wall of the pin (DSBF,wall)
The diffusivity of SBF through the porous steel wall of the pin, DSBF,wall , was calculated by
interpolating data based on SBF composition [15]. SBF contains mostly Na+ and Cl− in a 1:1
ratio, so the value of DSBF,wall , was calculated by averaging the De values for the Na+ solution and
theCl− solution [15].
DSBF,wall =
1
2
(De,Na+De,Cl)
(17)
DSBF,wall = 8.1∗10−11m2/s
Here, De,Na, the effective diffusivity ofNa+ solution in porous stainless wall with 19% porosity,
is 6.5 x 10−1110−11m2/s. De,Cl , the effective diffusivity ofCl− solution in the same porous stainless
wall, is 6.5 x 10−11m2/s. The calculated diffusivity of SBF through the porous steel wall of the pin
was 8.1 x 10−11m2/s.
2. Diffusivity of linezolid through the porous steel wall of the pin (DD,wall)
The diffusivity of linezolid through the porous steel wall of the pin, DD,wall , was calculated
using the effective diffusivity equation from literature [15]:
De =
ε
G
Dw
(18)
In the case of our project, ε , the porosity of the wall, is 0.17. The overall geometric factor, G,
is 4.2, adopted from Aldaba’s experimental results [15]. The bulk diffusion coefficient of linezolid
in SBF, Dw, is 4.22 x 10−10m2/s. Therefore, we obtained that the diffusivity of Linezolid through
the porous steel wall to be 1.70 x 10−11m2/s.
3. Concentration of SBF (CSBF )
The concentration of SBF outside the pin (CSBF ) was calculated assuming the molecular weight
of SBF was equivalent to the molecular weight of water, MWwater = 18.01528 g/mol. Because the
density of SBF is similar to that of the blood serum, the density of the blood serum was used as
ρSBF=1025000 g/m3. Therefore, we obtained Equation 11.
CSBF =
ρSBF
MWwater
(11)
The concentration of SBF outside the pin (CSBF ) was calculated to be 56869.15 mol/m3, or
1025 kg/m3.
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4. Initial concentration of the drug inside the silica beads (CDi)
The Initial concentration of the drug inside the silica beads (CDi) was calculated based on the
experimental parameters designed by Perez et al [8]. The total mass of drug inside the silica matrix,
mD, is 3.515 mg. The molecular weight of linezolid, MWD, is 337.351 g/mol. The volume of the
matrix, Vm, is 185.5766 mm3. The molecular weight of linezolid, MWD, is 337.351 g/mol [8]. The
value ofCDi was calculated as:
CDi =
mD
MWDVm
(20)
Therefore the initial concentration of the drug inside the silica beads (CDi) was found to be
56.0146 mol/m3.
5. Mass transfer coefficient of drug in SBF (h)
Under the condition of forced convective flow over a cylindrical surface, the mass transfer co-
efficient of drug in SBF was calculated, using the Equation 21.
h=
ShSBF ∗DD,SBF
d
(21)
The diameter of the pin, d, is 6.25 x 10−3 m. The diffusivity of drug in SBF (DD,SBF ) is 4.22 x
10−10 m2/s. The Sherwood number (ShSBF ) is the ratio of molecular mass transport resistance to
the convective mass transport resistance of the SBF. It is quantitatively defined in Equation 22.
ShSBF = B∗RenSBF ∗Sc1/3
(22)
The Reynolds number (ReSBF ) of SBF flow was calculated using Equation 23.
ReSBF =
uSBF ∗d ∗CSBF
µ
(23)
Here, the velocity of the SBF outside (µSBF ) is 1.5 x 10−6 m/s. The density of SBF (CSBF ) is
1025 kg/m3 [22,23]. The dynamic viscosity of SBF (µSBF ) is 1.5 mPa∗ s [24]. Plugging in these
values, we found that the Reynolds number for SBF flow is 1.3504 x 10−3 m/s. The very small
value for the Reynolds number suggests that the speed of fluid flow is so small that we can take it
to be almost stagnant. In this case, the value of Sherwood’s number can be approximated to be 2.
Using the newly found Sherwood’s number to solve for h, we obtained the mass transfer coefficient
of drug in SBF (h) to be 1.3504 x 10−7 m/s.
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